Royalty Pharma (RPRX) Divestments (2020 - 2026)
Royalty Pharma (RPRX) reported Divestments of $42.3 million for Q1 2026, up 16.67% on a YoY basis from $36.3 million in Q1 2025, and up 747.14% sequentially from $5.0 million in Q4 2025.
Royalty Pharma (RPRX) Divestments (2020 - 2026) Analysis & Trends
Royalty Pharma (RPRX) has 7 years of Divestments data on file, last reported at $42.3 million in Q1 2026.
- For the quarter ending Q1 2026, Divestments rose 16.67% year-over-year to $42.3 million; the trailing twelve-month figure through Mar 2026 stood at $110.6 million (up 103.3% YoY), and the FY2025 full-year result was $105.1 million, up 344.77% from the prior year.
- Divestments climbed to $42.3 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $62.4 million in Q2 2025 to a low of $905000.0 in Q3 2025.
- A 5-year average of $15.3 million and a median of $5.0 million in 2025 frame the typical range for Divestments.
- Peak annual rise in Divestments reached 1500.0% in 2025, while the deepest fall reached 91.77% in 2025.
- Tracing RPRX's Divestments over 5 years: stood at $5.8 million in 2022, then declined by 19.71% to $4.7 million in 2023, then sank by 30.34% to $3.2 million in 2024, then jumped by 53.95% to $5.0 million in 2025, then soared by 747.14% to $42.3 million in 2026.
- Business Quant data shows RPRX's Divestments at $42.3 million in Q1 2026, $5.0 million in Q4 2025, and $905000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Royalty Pharma | 25.78 Bn | 28.22 Bn | - | 42.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.31 Mn |
| Dec 31, 2025 | 4.99 Mn |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 62.40 Mn |
| Mar 31, 2025 | 36.26 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 34.77 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 6.80 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Jun 30, 2021 | 4.70 Mn |
| Sep 30, 2020 | 4.20 Mn |
| Jun 30, 2020 | 5.30 Mn |